Reduced immunogenicity of the mRNA vaccine BNT162b2 in patients with IPF

被引：0
|
作者：
Karampitsakos, T. [1 ]
Dimeas, I [2 ]
Tsiri, P. [1 ]
Sotiropoulou, V [1 ]
Tomos, I [3 ]
Papanikolaou, I [4 ]
Katsaras, M. [1 ]
Kirgou, P. [2 ]
Daniil, Z. [2 ]
Gourgoulianis, K. [2 ]
Papalexatos, D. [1 ]
Sampsonas, F. [1 ]
Manali, E. [3 ]
Papiris, S. [3 ]
Bouros, D. [5 ]
Tzouvelekis, A. [1 ]
Papaioannoui, o [1 ]
机构：
[1] Univ Hosp Patras, Dept Resp Med, Patras, Greece
[2] Univ Thessaly, Med Sch, Dept Resp Med, Larisa, Greece
[3] Natl & Kapodistrian Univ Athens, ATTIKON Univ Hosp, Athens Med Sch, Pulm Med Dept 2, Athens, Greece
[4] Corfu Gen Hosp, Resp Med Dept, Corfu, Greece
[5] Natl & Kapodistrian Univ Athens, Hosp Thorac Dis, Acad Dept Pneumonol 1, Med Sch,SOTIRIA, Athens, Greece
来源：
EUROPEAN RESPIRATORY JOURNAL | 2022年 / 60卷
关键词：
D O I：
10.1183/13993003.congress-2022.972
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
972
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Immunogenicity of BNT162b2 vaccine after two and three doses: Correspondence
    Daungsupawong, H.
    Wiwanitkit, V.
    MEDICINA DE FAMILIA-SEMERGEN, 2024, 50 (04):
  • [32] Immunogenicity of the BNT162b2 mRNA COVID-19 vaccine in patients with primary brain tumors: a prospective cohort study
    Amir Massarweh
    Roi Tschernichovsky
    Amos Stemmer
    Alexandra Benouaich-Amiel
    Tali Siegal
    Noa Eliakim-Raz
    Salomon M. Stemmer
    Shlomit Yust-Katz
    Journal of Neuro-Oncology, 2022, 156 : 483 - 489
  • [33] Immunogenicity Parameters of Cancer Patients Receiving the mRNA Vaccine BNT162b2 While Obtaining Radiotherapy: A Longitudinal Cohort Evaluation
    Thoene, Paul
    Egger, Margot
    Geroldinger-Simic, Marija
    Kindermann, Harald
    Kocik, Lukas
    Karasek, Nicola
    Fischerlehner, Barbara
    Spiegl, Kurt
    Gruber, Georg
    Aschacher, Bernhard
    Dieplinger, Benjamin
    Clodi, Martin
    Geinitz, Hans
    VACCINES, 2024, 12 (03)
  • [34] Safety and immunogenicity of the BNT162b2 mRNA Covid-19 vaccine in patients with chronic lymphocytic leukemia: a prospective study
    Diamantopoulos, Panagiotis T.
    Stafylidis, Christos
    Vlachopoulou, Dimitra
    Kontandreopoulou, Christina-Nefeli
    Giannakopoulou, Nefeli
    Vardaka, Maria
    Mpouhla, Anthi
    Mastrogianni, Elpida
    Variami, Eleni
    Galanopoulos, Athanasios
    Pappa, Vasiliki
    Psichogiou, Mina
    Hatzakis, Angelos
    Viniou, Nora-Athina
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2022, 13
  • [35] Immunogenicity of the BNT162b2 mRNA COVID-19 vaccine in patients with primary brain tumors: a prospective cohort study
    Massarweh, Amir
    Tschernichovsky, Roi
    Stemmer, Amos
    Benouaich-Amiel, Alexandra
    Siegal, Tali
    Eliakim-Raz, Noa
    Stemmer, Salomon M.
    Yust-Katz, Shlomit
    JOURNAL OF NEURO-ONCOLOGY, 2022, 156 (03) : 483 - 489
  • [36] BNT162b2 mRNA Vaccine interference with Co-Administration of Tdap Vaccine
    Chilimuri, Sridhar
    Mantri, Nikhitha
    Shrestha, Elina
    Sun, Haozhe
    Gongati, Sudharsan
    Zahid, Maleeha
    Kelly, Paul
    AMERICAN JOURNAL OF CASE REPORTS, 2021, 22
  • [37] Immunogenicity against the BNT162b2 mRNA COVID-19 Vaccine in Rheumatic Disease Patients Receiving Immunosuppressive Therapy
    Sugihara, Koichi
    Wakiya, Risa
    Shimada, Hiromi
    Kameda, Tomohiro
    Nakashima, Shusaku
    Kato, Mikiya
    Miyagi, Taichi
    Mizusaki, Mao
    Mino, Rina
    Nomura, Yumi
    Inoo, Masayuki
    Kadowaki, Norimitsu
    Dobashi, Hiroaki
    INTERNAL MEDICINE, 2022, 61 (13) : 1953 - 1958
  • [38] Efficacy and toxicity of BNT162b2 vaccine in cancer patients
    Ben-Aharon, I.
    Waldhorn, I.
    Holland, R.
    Peer, A.
    Halberthal, M.
    Goshen-Lago, T. G.
    ANNALS OF ONCOLOGY, 2021, 32 : S1130 - S1130
  • [39] Safety and Immunogenicity of the BNT162b2 Vaccine Coadministered with Seasonal Inactivated Influenza Vaccine in Adults
    Murdoch, Louise
    Quan, Karen
    Baber, James A.
    Ho, Agnes W. Y.
    Zhang, Ying
    Xu, Xia
    Lu, Claire
    Cooper, David
    Koury, Kenneth
    Lockhart, Stephen P.
    Anderson, Annaliesa S.
    Tuereci, Ozlem
    Sahin, Ugur
    Swanson, Kena A.
    Gruber, William C.
    Kitchin, Nicholas
    INFECTIOUS DISEASES AND THERAPY, 2023, 12 (09) : 2241 - 2258
  • [40] Safety and Immunogenicity of the BNT162b2 Vaccine Coadministered with Seasonal Inactivated Influenza Vaccine in Adults
    Louise Murdoch
    Karen Quan
    James A. Baber
    Agnes W. Y. Ho
    Ying Zhang
    Xia Xu
    Claire Lu
    David Cooper
    Kenneth Koury
    Stephen P. Lockhart
    Annaliesa S. Anderson
    Özlem Türeci
    Uğur Şahin
    Kena A. Swanson
    William C. Gruber
    Nicholas Kitchin
    Infectious Diseases and Therapy, 2023, 12 : 2241 - 2258
12345